Atara Biotherapeutics (ATRA) came out with a quarterly loss of $2.93 per share ... estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based ...

Analysts are estimating that Atara Biotherapeutics will report an earnings per share (EPS) of $-1.93. Atara Biotherapeutics ...

How to use Atara Biotherapeutics Inc. ATRA as a Forecasting Tool ...

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a loss of $21.9 million in its third quarter. On a per-share basis, the Thousand Oaks, ...

Atara Biotherapeutics (NASDAQ:ATRA) stock is falling hard on Thursday after the therapeutics company announced results from a Phase 2 clinical trial. The bad news for ATRA stock investors is the ...

Short interest in Atara Biotherapeutics Inc (NASDAQ:ATRA) increased during the last ... betting on the decline of Atara Biotherapeutics's stock. Short interest data is updated every two weeks.

Yatra Online, Inc. (YTRA) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago. These figures ...

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...